Phase 2 genes are upregulated during oxidative stress, members include heme oxygenase 1 (HO-1), glutathione S-transferase (GST), and NADP-quinone reductase and therefore have been explored as possible cancer therapeutic targets [163,164,165]. This evidence concerns the gene HMOX1 and cancer.